Life Science Investing BioVaxys Strengthens Scientific Team with Addition of Former IMV Vice President of R&D
Life Science Investing BioVaxys Licensee SpayVac-for-Wildlife, Inc., Reports Further Positive Single-Dose Efficacy Data for Its Immunocontraceptive Vaccine and Initiation of Regulatory Submission Process
Life Science Investing BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement
